TRU-Cut Biopsy in Tumor cHaracterisation

Recruiting now

Conditions studied: Tumor

In brief

Tru-cut biopsy (TCB) is a minimally invasive method to get an adequate sample from the lesion in order to tailor the appropriate management avoiding unnecessary surgery. The aim of our trial is to evaluate the adequacy, accuracy and safety of the method related to the final histology as reference standard.

Key facts

Study ID

NCT06816160

Run by

General University Hospital, Prague

People needed

250

Starts

2024-02-01

Expected to finish

2027-01-31

Last updated by the study team

2025-02-10

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may not qualify if…

• Considered by the investigator to be unsuitable for any treatment
• Early stage disease
• Age <18 years

Where it is running

• Department of Gynecology, Obstetrics and Neonatology of First Faculty of Medicine and General University Hospital in Prague — Prague, Czechia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.